Dr. Corey Hebert hosts a four-part video series on "What You Need to Know About Sickle Cell Anemia"
Medunik USA sponsors video series to support parents caring for their child's sickle cell disease, which is causing morbidity and mortality to the African American community.
ROSEMONT, Pa., June 22, 2020 /CNW/ - Sickle cell anemia patients and their families can learn more about the disease in a new video series sponsored by Medunik USA, a company dedicated to improving the health and quality of life of Americans with rare diseases.
Entitled "What You Need to Know About Sickle Cell Anemia", the four-part video series is hosted by Dr. Corey Hebert, MD, Chief Medical Officer at Dillard University and well-known medical broadcast journalist from various national television networks and outlets.
"Sickle cell disease is causing major morbidity and mortality to the African-American community and with the help of these informative videos I want to see the needle moved in the right direction", said Dr. Hebert, a paid spokesperson for Medunik USA. The videos provide information on symptoms and aim to help parents better understand the disease following their child's diagnosis, including treatment options.
Our society continues to suffer from the wounds of racial injustice, economic inequality and disparities in access to quality healthcare. This is evident on a large scale with how the African American community has been disproportionately impacted by COVID-19. This problem is also apparent when talking about diseases and conditions that primarily affect African American's like sickle cell anemia and it is time to talk about what can be done to help treat this genetic disorder.
100,000 Americans Affected by Sickle Cell Disease
Sickle cell disease (SCD) is a rare, inherited blood disorder, causing debilitating pain and disability, and decreasing life expectancy by 25 to 30 years. It is characterized by the presence of sickle or crescent-shaped red blood cells that become stuck in the blood vessels, blocking blood flow, thus causing crippling pain and organ damage, which require hospitalization.
An Online Educational Resource
"At Medunik USA, our mission is to provide Americans who have rare diseases with the life-changing and potentially life-saving treatment options they deserve", indicated Tanya Carro, General Manager, Medunik USA. "Families who have a child with a rare disease like sickle cell anemia may feel 'orphaned' by the healthcare system and left to cope alone. We are hoping that the videos will provide much needed support and information to parents caring for a sick child."
Siklos®: The Importance of Early Treatment
Early treatment of symptoms is key to helping pediatric sickle cell disease patients live a healthier childhood. Medunik USA is proud to hold the exclusive rights to market and distribute Siklos® (hydroxyurea) in the United States. Siklos® has a Boxed Warning regarding low blood cell counts and cancer; please read Important Safety Information below.
Siklos® is the first and only FDA-approved hydroxyurea-based treatment for use in pediatric patients with sickle cell anemia. It is indicated to reduce the frequency of painful crises and the need forblood transfusions in children, 2 years of age and older, with sickle cell anemia with recurrent moderate to severe painful crises. Moreover, Siklos® is available in triple-scored 1,000 mg tablets and 100 mg tablets to help optimize dosing.
About SIKLOS® (hydroxyurea)
WARNING: LOW BLOOD CELL COUNT and CANCER
WHAT IS THE MOST IMPORTANT INFORMATION YOU SHOULD KNOW ABOUT SIKLOS®?
WHO SHOULD NOT TAKE SIKLOS®?
WHAT SHOULD YOU TELL YOUR HEALTHCARE PROVIDER BEFORE TAKING SIKLOS®?
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
WHAT ARE THE POSSIBLE SIDE EFFECTS OF SIKLOS®?
The most common side effects include:
These are not all the possible side effects of Siklos®.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please read the Full Prescribing Information, including Boxed Warning, Medication Guide and Instructions for Use at www.siklosusa.com
For more information about Siklos®, we invite you to contact our Medical Information Service at 1 844-884-5520 or https://www.medunikusa.com/en/medical-information-service
About Medunik USA
View original content to download multimedia:http://www.prnewswire.com/news-releases/dr-corey-hebert-hosts-a-four-part-video-series-on-what-you-need-to-know-about-sickle-cell-anemia-301080681.html
SOURCE Medunik USA